Purchases and Sales Made in Q1 2025 in Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC) during Q1 2025. The information is specifically focused on institutions that hold shares of Oric Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Apr 10, 2025
Q1 2025
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-6.27K- 3.85% |
$35K - $78.6K
|
157K
$1.69M
|
|
|
May 07, 2025
Q1 2025
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-6.89K- 26.53% |
$38.4K - $86.4K
|
19.1K
$205K
|
|
|
May 13, 2025
Q1 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-7.25K- 1.31% |
$40.4K - $90.9K
|
547K
$5.89M
|
|
|
May 09, 2025
Q1 2025
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-9.45K- 2.26% |
$52.7K - $119K
|
409K
$4.4M
|
|
|
May 15, 2025
Q1 2025
|
Barclays PLC
London, X0 |
SELL
|
- |
-12.9K- 11.25% |
$72K - $162K
|
102K
$1.1M
|
|
|
May 15, 2025
Q1 2025
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-13.8K- 94.24% |
$77.1K - $173K
|
844
$9.09K
|
|
|
May 15, 2025
Q1 2025
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-38.4K- 14.05% |
$214K - $481K
|
235K
$2.53M
|
|
|
May 15, 2025
Q1 2025
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-40.6K- 18.49% |
$226K - $509K
|
179K
$1.92M
|
|
|
Apr 15, 2025
Q1 2025
|
Sg Americas Securities, LLC
|
SELL
|
- |
-46.4K- 69.99% |
$259K - $582K
|
19.9K
$214K
|
|
|
May 15, 2025
Q1 2025
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-49.2K- 3.52% |
$274K - $617K
|
1.35M
$14.5M
|
|
|
May 15, 2025
Q1 2025
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-55.3K- 83.16% |
$309K - $693K
|
11.2K
$121K
|
|
|
May 15, 2025
Q1 2025
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-62.7K- 44.88% |
$350K - $786K
|
77K
$829K
|
|
|
May 15, 2025
Q1 2025
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-127K- 72.75% |
$710K - $1.6M
|
47.6K
$513K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-179K- 51.44% |
$997K - $2.24M
|
169K
$1.82M
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-297K- 41.06% |
$1.66M - $3.73M
|
427K
$4.6M
|
|
|
May 15, 2025
Q1 2025
|
Superstring Capital Management LP
New York, NY |
SELL
|
- |
-762K- 48.18% |
$4.25M - $9.55M
|
819K
$8.82M
|
|
|
May 15, 2025
Q1 2025
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-1.21M- 27.58% |
$6.76M - $15.2M
|
3.18M
$34.3M
|
|
|
May 15, 2025
Q1 2025
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-2.48M- 63.73% |
$13.8M - $31.1M
|
1.41M
$15.2M
|